tDCS for Pain Modulation in Knee Osteoarthritis
NCT: NCT07291791 · ACTIVE_NOT_RECRUITING
Brief Summary
Knee osteoarthritis (KOA) is a common condition that causes long-lasting knee pain and difficulty with daily activities. Many patients have pain that is stronger than expected from joint changes because the nervous system becomes more sensitive to pain. Transcranial direct current stimulation (tDCS) is a non-invasive technique that uses a small electrical current applied to the scalp to help reduce pain sensitivity. This study will test whether active tDCS over the primary motor cortex can reduce pain and improve function in people with knee osteoarthritis. A total of 102 participants will be randomly assigned to receive either active tDCS or sham (placebo) stimulation. All participants will receive 15 sessions over three weeks. We will measure pain intensity, pain sensitivity, physical function, depression, cognition, and quality of life before the treatment, after the 3-week treatment program, and again at the 1-month follow-up.
Frequently Asked Questions
What is tDCS for Pain Modulation in Knee Osteoarthritis?
tDCS for Pain Modulation in Knee Osteoarthritis is a clinical trial registered under NCT07291791. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT07291791?
The current status of NCT07291791 (tDCS for Pain Modulation in Knee Osteoarthritis) is: ACTIVE_NOT_RECRUITING.
When did tDCS for Pain Modulation in Knee Osteoarthritis start?
tDCS for Pain Modulation in Knee Osteoarthritis started on 2025-12-20.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.